Archive for the ‘Pain / Anesthetics’ Category
Thursday, February 28th, 2008
Aetna has announced that, based on input from the AGA Institute and discussions with a number of gastroenterologists, it will not implement Clinical Policy Bulletin 0740 on April 1, 2008, as planned. This policy would have restricted the use of an anesthesia professional in standard upper or lower endoscopic procedures, ...
Posted in Pain / Anesthetics | No Comments »
Monday, February 25th, 2008
New research to be carried out at The University of Nottingham could have a major impact on the way that people struggling with low back pain are helped to stay in work.
Back pain is one of the main causes of absence from work in the UK. In 2004-5 approximately 34,000 ...
Posted in Pain / Anesthetics | No Comments »
Friday, February 22nd, 2008
Patients suffering from fibromyalgia could benefit significantly from regular exercise in a heated swimming pool, a study published in the open access journal Arthritis Research & Therapy shows. The findings suggest a cost effective way of improving quality of life for patients with this often-debilitating disorder.
Fibromyalgia is a common, painful ...
Posted in Pain / Anesthetics | No Comments »
Wednesday, February 20th, 2008
A new study demonstrates that high levels of MAO-B, an enzyme that regulates nerve activity in the brain, cause Parkinson's-like symptoms in mice genetically engineered to overexpress the protein. Furthermore, drugs currently used as an adjunct therapy for Parkinson's in humans prevented the development of Parkinson's symptoms in these same ...
Posted in Pain / Anesthetics | No Comments »
Monday, February 18th, 2008
Diamyd Medical (NASDAQ:DMYDY)(STO:DIAMB) announced that it has received approval from the U.S. FDA to initiate a Phase I study in chronic pain using NP2, the company's first drug candidate in its Nerve Targeting Drug Delivery System (NTDDS) gene therapy platform.
NP2, developed by the company's U.S. subsidiary, Diamyd, Inc., in Pittsburgh, ...
Posted in Pain / Anesthetics | No Comments »
Monday, February 18th, 2008
Canadians are being advised not to use 25 mcg/hr Duragesic (fentanyl transdermal system) patches (Janssen-Ortho Inc.) and 25 mcg/hr Ran Fentanyl Transdermal System patches (Ranbaxy). The manufacturers are voluntarily recalling Duragesic and Ran Fentanyl Transdermal System 25 mcg/hr patches as it is possible they may have a cut along one ...
Posted in Pain / Anesthetics | No Comments »
Wednesday, November 7th, 2007
Nitec Pharma AG, an emerging specialty pharma company, announces the signing of an agreement with PAZ GmbH for the exclusive worldwide rights to Tarenflurbil, PAZ's anti-inflammatory drug, for the treatment of chronic inflammation and pain. The in-licensing of Tarenflurbil broadens Nitec's pipeline and underscores the company's ambition to become a ...
Posted in Pain / Anesthetics | No Comments »
Thursday, November 1st, 2007
The unexplained pain experienced by patients with fibromyalgia is the result of a mismatch between sensory and motor systems, new research suggests.
In a study published in the journal Rheumatology, researchers asked patients to look at a reflection of one arm whilst moving their other in a different direction which was ...
Posted in Pain / Anesthetics | No Comments »
Friday, October 26th, 2007
KV Pharmaceutical Company (NYSE: KVa/KVb) announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its application for the 100 mg and 200 mg strengths of Morphine ER Tablets (MS Contin(R) marketed by Purdue Pharma L.P.). This approval now ...
Posted in Pain / Anesthetics | No Comments »
